Medstar Saint Mary's Hospital | |
25500 Point Lookout Road, Leonardtown, Maryland 20650 | |
(301) 475-6001 | |
Name | Medstar Saint Mary's Hospital |
---|---|
Type | Acute Care Hospital |
Location | 25500 Point Lookout Road, Leonardtown, Maryland |
Ownership | Voluntary non-profit - Private |
Emergency Services | Yes |
Medicare ID (CCN) | 210028 |
NPI Number | 1770691024 |
Organization Name | ST. MARY'S HOSPITAL OF ST. MARY'S COUNTY, INC |
Address | 25500 Point Lookout Rd, Health Connections, Leonardtown, MD 20650 |
Hospital Type | General Acute Care Hospital - Rural |
Phone Number | 301-475-6185 |
News Archive
David H. Fater, CEO of Vicor Technologies, Inc., today announced that Andriy Batchinsky, MD, a researcher with the U.S. Army Institute of Surgical Research (USAISR), will present findings from a study of Vicor's PD2i VS™ (Vital Sign) at the American Heart Association's Resuscitation Science Symposium 2009 on November 14-15, 2009 in Orlando, Florida.
BioDelivery Sciences International, Inc. announced that the company has been granted a meeting with the U.S. Food and Drug Administration (FDA) to discuss the planned Investigational New Drug (IND) application for BDSI's antiemetic (anti-nausea and vomiting) product candidate, BEMA Granisetron. The meeting will take place on March 17, 2010. The company will discuss with the FDA clinical development and regulatory plans for BEMA Granisetron, which is anticipated to enter Phase 1 studies in the second quarter of 2010.
Particular components of inflammasomes-protein complexes needed for generating immune responses to pathogens and cellular damage-lessen the severity of colitis and colitis-associated colon cancer in mice, according to a study published online this week in the Journal of Experimental Medicine.
Clarient, Inc. a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that the United States Patent and Trademark Office and the European Patent Office have allowed patents covering the technology behind Clarient Insight Dx Mammostrat, a test designed to aid in the classification of the risk of recurrence of breast cancer following surgery and initial treatment.
Mondial Assistance today announced its participation in a new global fundraising initiative, aptly named: MASSIVEGOOD. The aim of MASSIVEGOOD is to encourage consumers to make small, voluntary financial contributions (around $2, for example) when they make a travel-related purchase.
› Verified 9 days ago
NPI Number | 1780650473 |
Organization Name | ST MARYS HOSPITAL OF ST MARYS COUNTY INC |
Doing Business As | MEDSTAR ST. MARY'S HOSPITAL |
Address | 25500 Point Lookout Rd, Leonardtown, MD 20650 |
Hospital Type | General Acute Care Hospital |
Phone Number | 301-475-6003 |
News Archive
David H. Fater, CEO of Vicor Technologies, Inc., today announced that Andriy Batchinsky, MD, a researcher with the U.S. Army Institute of Surgical Research (USAISR), will present findings from a study of Vicor's PD2i VS™ (Vital Sign) at the American Heart Association's Resuscitation Science Symposium 2009 on November 14-15, 2009 in Orlando, Florida.
BioDelivery Sciences International, Inc. announced that the company has been granted a meeting with the U.S. Food and Drug Administration (FDA) to discuss the planned Investigational New Drug (IND) application for BDSI's antiemetic (anti-nausea and vomiting) product candidate, BEMA Granisetron. The meeting will take place on March 17, 2010. The company will discuss with the FDA clinical development and regulatory plans for BEMA Granisetron, which is anticipated to enter Phase 1 studies in the second quarter of 2010.
Particular components of inflammasomes-protein complexes needed for generating immune responses to pathogens and cellular damage-lessen the severity of colitis and colitis-associated colon cancer in mice, according to a study published online this week in the Journal of Experimental Medicine.
Clarient, Inc. a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that the United States Patent and Trademark Office and the European Patent Office have allowed patents covering the technology behind Clarient Insight Dx Mammostrat, a test designed to aid in the classification of the risk of recurrence of breast cancer following surgery and initial treatment.
Mondial Assistance today announced its participation in a new global fundraising initiative, aptly named: MASSIVEGOOD. The aim of MASSIVEGOOD is to encourage consumers to make small, voluntary financial contributions (around $2, for example) when they make a travel-related purchase.
› Verified 9 days ago
Able to receive lab results electronically | No |
Able to track patients' lab results, tests, and referrals electronically between visits | Not Available |
News Archive
David H. Fater, CEO of Vicor Technologies, Inc., today announced that Andriy Batchinsky, MD, a researcher with the U.S. Army Institute of Surgical Research (USAISR), will present findings from a study of Vicor's PD2i VS™ (Vital Sign) at the American Heart Association's Resuscitation Science Symposium 2009 on November 14-15, 2009 in Orlando, Florida.
BioDelivery Sciences International, Inc. announced that the company has been granted a meeting with the U.S. Food and Drug Administration (FDA) to discuss the planned Investigational New Drug (IND) application for BDSI's antiemetic (anti-nausea and vomiting) product candidate, BEMA Granisetron. The meeting will take place on March 17, 2010. The company will discuss with the FDA clinical development and regulatory plans for BEMA Granisetron, which is anticipated to enter Phase 1 studies in the second quarter of 2010.
Particular components of inflammasomes-protein complexes needed for generating immune responses to pathogens and cellular damage-lessen the severity of colitis and colitis-associated colon cancer in mice, according to a study published online this week in the Journal of Experimental Medicine.
Clarient, Inc. a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that the United States Patent and Trademark Office and the European Patent Office have allowed patents covering the technology behind Clarient Insight Dx Mammostrat, a test designed to aid in the classification of the risk of recurrence of breast cancer following surgery and initial treatment.
Mondial Assistance today announced its participation in a new global fundraising initiative, aptly named: MASSIVEGOOD. The aim of MASSIVEGOOD is to encourage consumers to make small, voluntary financial contributions (around $2, for example) when they make a travel-related purchase.
› Verified 9 days ago
Medstar Saint Mary's Hospital Acute Care Hospital Location: 25500 Point Lookout Road, Leonardtown, Maryland 20650 Phone: (301) 475-6001 |